发布求助
文献互助 智能选刊 最新文献

PharmacoEconomics & Outcomes News最新文献

筛选
英文 中文
Monoclonal antibodies in metastatic colorectal cancer: benefits at high cost 单克隆抗体在转移性结直肠癌中的应用:高成本效益
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08244-9
{"title":"Monoclonal antibodies in metastatic colorectal cancer: benefits at high cost","authors":"","doi":"10.1007/s40274-021-08244-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08244-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"40 1","pages":"13 - 13"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74424159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France SAPIEN 3 TAVI与外科瓣膜置换术治疗严重主动脉瓣狭窄的成本效益比较
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08253-8
{"title":"SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France","authors":"","doi":"10.1007/s40274-021-08253-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08253-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"76 1","pages":"22 - 22"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78688516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia 澳大利亚低风险局部前列腺癌放射治疗的成本效益选择
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08250-8
{"title":"Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia","authors":"","doi":"10.1007/s40274-021-08250-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08250-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"29 1","pages":"19 - 19"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86946727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct healthcare costs of patients with dyshidrotic eczema in the USA? 在美国，易湿性湿疹患者的直接医疗费用是多少?
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08237-x
{"title":"Direct healthcare costs of patients with dyshidrotic eczema in the USA?","authors":"","doi":"10.1007/s40274-021-08237-x","DOIUrl":"https://doi.org/10.1007/s40274-021-08237-x","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"22 1","pages":"6 - 6"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80707589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns about rollout of inclisiran in primary care in England 对在英格兰初级保健中推出inclisiran的担忧
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08233-x
{"title":"Concerns about rollout of inclisiran in primary care in England","authors":"","doi":"10.1007/s40274-021-08233-x","DOIUrl":"https://doi.org/10.1007/s40274-021-08233-x","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"67 1","pages":"2 - 2"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81128889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population genomic screening of all Australian adults for FH could be cost effective 对所有澳大利亚成年人进行FH人群基因组筛查可能具有成本效益
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08249-9
{"title":"Population genomic screening of all Australian adults for FH could be cost effective","authors":"","doi":"10.1007/s40274-021-08249-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08249-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"108 1","pages":"18 - 18"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87586902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark 在丹麦，对于2型糖尿病，Semaglutide + metformin与恩格列净+ metformin相比没有成本效益
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08254-8
A. cost-utility
{"title":"Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark","authors":"A. cost-utility","doi":"10.1007/s40274-021-08254-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08254-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"4 1","pages":"23 - 23"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90186661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to prescription drug access within US commercial insurance 美国商业保险中处方药获取的障碍
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08264-7
{"title":"Barriers to prescription drug access within US commercial insurance","authors":"","doi":"10.1007/s40274-021-08264-7","DOIUrl":"https://doi.org/10.1007/s40274-021-08264-7","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"266 1","pages":"33 - 33"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77494443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Willingness to pay for cancer treatments and outcomes: QOL valued similarly to 1-year survival 支付癌症治疗费用的意愿和结果:生活质量与1年生存率相似
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08263-7
{"title":"Willingness to pay for cancer treatments and outcomes: QOL valued similarly to 1-year survival","authors":"","doi":"10.1007/s40274-021-08263-7","DOIUrl":"https://doi.org/10.1007/s40274-021-08263-7","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"16 1","pages":"32 - 32"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74376387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making 法国创新药物的报销和定价:确定为决策提供信息的标准
PharmacoEconomics & Outcomes News Pub Date : 2021-12-01 DOI: 10.1007/s40274-021-08251-8
{"title":"Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making","authors":"","doi":"10.1007/s40274-021-08251-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08251-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"06 1","pages":"20 - 20"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86356327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信